Member Info for chrishutch

I am new to this company so forgive me while I dig around but £17m it looks cheap here, really cheap.

Some have cashed in their chips waaaaay tooo early and are going to have to watch it climb without them. Multiple projects. Results at Alford East are worthy of much more. 73m at 1% cu from 6m. THR can build on those results with assays to come. Kapunda Drilling. ASX pushed this to 1.10 over night and no doubt they will continue buying up the weakness and push it higher. Uranium companies have been rocketing across the planet and copper and...well you get the idea.

This is the company you want to be holding.

I am new to this company but £17m so forgive me while I dig around but it looks cheap here, really cheap.

Some have cashed in their chips waaaaay tooo early and are going to have to watch it climb without them. Multiple projects. Results at Alford East are worthy of much more. 73m at 1% cu from 6m. THR can build on those results with assays to come. Kapunda Drilling. ASX pushed this to 1.10 over night and no doubt they will continue buying up the weakness and push it higher. Uranium companies have been rocketing across the planet and copper and...well you get the idea.

This is the company you want to be holding.

Video: https://vimeo.com/607174668

haha - give it time! It is coming!

by the looks

Fri, 17th Sep 2021 07:00

RNS Number : 0618M
Cizzle Biotechnology Holdings PLC
17 September 2021

17 September 2021
Cizzle Biotechnology Holdings Plc
("Cizzle Biotechnology" or the "Company")

New Research Agreement with the University of York for Cancer Tests

Cizzle Biotechnology, the UK based diagnostics developer, is pleased to announce that it has entered into a new research agreement with the University of York for the development and validation of molecular tools with potential applications in cancer diagnosis and therapy.

The Company's wholly owned subsidiary Cizzle Biotechnology Limited was a spin out from the University of York based on original research and development undertaken in laboratories at the University, under the direction of Professor Dawn Coverley. The new agreement extends that relationship and provides seconded staff and access to the University's state of the art research facilities to support reagent generation work in collaboration with our recently announced Contract Research Organisation (CRO) partner Fairjouney Biologics.

Commenting, Allan Syms, Executive Chairman of Cizzle Biotechnology, said: "We are thrilled to be able to cement our long-standing relationship with the University of York, a member of the Russell Group of research-intensive universities and one of the world's premier institutions for inspirational and life-changing research. This new agreement will provide valuable additional resource and capability for developing our blood test for the early detection of lung cancer, and potentially other forms of cancer."

Great to see this

Yes great news!

Well done to the team!

NT to buy

Two down days in a row. Oh my. lol.

https://www.youtube.com/watch?v=oFH62JpEVHI

wish you luck T.Rat

We have been in this range for a little while now, clearly people are loading up down here and offloading in the 30s and repeat. Always a good idea to keep some in case it it breaks out higher on the next go, assuming you are trading the range.

was that the bottom?

GREAT PRICE

Filled - will I be lucky with this one I suspect so.

I have an order at 27 but they are not touching it. Do

Healthy debate is always welcomed. I quite enjoy watching this board and the fun and games we see.

:-)

The first of many blue days hopefully.